Literature DB >> 26689329

B cell development in chromosome 22q11.2 deletion syndrome.

Beata Derfalvi1, Kelly Maurer2, Donna M McDonald McGinn3, Elaine Zackai3, Wenzhao Meng4, Eline T Luning Prak4, Kathleen E Sullivan5.   

Abstract

Chromosome 22q11.2 deletion syndrome is a common immune deficiency associated with thymic hypoplasia. Most patients did not survive until the mid-1980s and now there is a growing adult population. B cell and immunoglobulin defects have been described and appear to be increased in the adult population. We used flow cytometry, B cell stimulation and repertoire analysis to understand B cell function. B cell production at early stages appeared to be normal in patients but adult patients exhibited a deficit of switched memory B cells. Follicular helper T cells were present at higher percentages in patients and they exhibited a more activated phenotype in patients compared to controls. In spite of that, somatic hypermutation was decreased in patients compared to controls at all ages. Fewer mutations per clone were seen, strongly implicating aberrant T cell help. Therefore, patients with chromosome 22q11.2 deletion syndrome have a progressive decrease in switched memory B cells and evidence of compromised T cell help. In children, evidence of compromised T cell help is limited to decreased somatic hypermutation. With age, greater manifestations become apparent even though a minority of patients have hypogammaglobulinemia. As this population ages, this has important implications for management.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  22q11.2 deletion syndrome; DiGeorge syndrome; Follicular helper T cells; Immunoglobulin; Somatic hypermutation; Switched memory B cells; TBX1

Mesh:

Substances:

Year:  2015        PMID: 26689329     DOI: 10.1016/j.clim.2015.12.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

Review 1.  B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review.

Authors:  Marie Ghraichy; Jacob D Galson; Dominic F Kelly; Johannes Trück
Journal:  Immunology       Date:  2017-12-18       Impact factor: 7.397

2.  Cosmc is required for T cell persistence in the periphery.

Authors:  Christopher E Cutler; Mark B Jones; Alicia A Cutler; Amanda Mener; Connie M Arthur; Sean R Stowell; Richard D Cummings
Journal:  Glycobiology       Date:  2019-10-21       Impact factor: 4.313

3.  Characteristics and Outcomes of Heart Transplantation in DiGeorge Syndrome.

Authors:  Peter Woolman; David W Bearl; Jonathan H Soslow; Debra A Dodd; Cary Thurm; Matt Hall; Brian Feingold; Justin Godown
Journal:  Pediatr Cardiol       Date:  2019-02-07       Impact factor: 1.655

Review 4.  Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).

Authors:  Caroline Y Kuo; Rebecca Signer; Sulagna C Saitta
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-30       Impact factor: 4.806

Review 5.  Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome.

Authors:  Blaine Crowley; Melanie Ruffner; Donna M McDonald McGinn; Kathleen E Sullivan
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

6.  Unexpected combination: DiGeorge syndrome and myeloperoxidase deficiency.

Authors:  Simona Abraitytė; Elisabeth Kotsi; Lisa Anne Devlin; John David Moore Edgar
Journal:  BMJ Case Rep       Date:  2020-02-26

7.  Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Authors:  Dita Gratzinger; Elaine S Jaffe; Amy Chadburn; John K C Chan; Daphne de Jong; John R Goodlad; Jonathan Said; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

8.  Long-Term Follow-Up of Newborns with 22q11 Deletion Syndrome and Low TRECs.

Authors:  Jenny Lingman Framme; Christina Lundqvist; Anna-Carin Lundell; Pauline A van Schouwenburg; Andri L Lemarquis; Karolina Thörn; Susanne Lindgren; Judith Gudmundsdottir; Vanja Lundberg; Sofie Degerman; Rolf H Zetterström; Stephan Borte; Lennart Hammarström; Esbjörn Telemo; Magnus Hultdin; Mirjam van der Burg; Anders Fasth; Sólveig Oskarsdóttir; Olov Ekwall
Journal:  J Clin Immunol       Date:  2022-01-26       Impact factor: 8.542

9.  Follicular Helper T Cells in DiGeorge Syndrome.

Authors:  Adam Klocperk; Zuzana Paračková; Markéta Bloomfield; Michal Rataj; Jan Pokorný; Susanne Unger; Klaus Warnatz; Anna Šedivá
Journal:  Front Immunol       Date:  2018-07-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.